
FDA Approves GSK's Pentavalent Meningococcal Vaccine
The US Food and Drug Administration (FDA) has approved GSK’s pentavalent meningococcal vaccine, Penmenvy, for children and young adults aged 10 to 25 years. This new vaccine provides protection against five meningococcal serogroups by combining components …